Suppr超能文献

行政命令12866:政府新监管计划在风险、收益和成本方面的利弊。

Executive Order 12866: advantages and disadvantages of the administration's new regulatory plan on risk, benefit, and costs.

作者信息

Barnard R C

机构信息

Cleary, Gottlieb, Steen & Hamilton, 1752 N Street, NW, Washington, DC, 20036, USA.

出版信息

Regul Toxicol Pharmacol. 1996 Jun;23(3):178-82. doi: 10.1006/rtph.1996.0041.

Abstract

The 1993 Executive Order 12866 as implemented by the 1996 OMB document proposes a new paradigm for the evaluation of risks, benefits, and costs. The new regulatory plan would replace the current methodology in two ways. In place of the current methodology for risk assessment based on conservative generic default assumptions that provide an upper-bound risk value that is treated as the "benefit," the new regulatory plan establishes a state of the art guidance for the economic evaluation of risks, benefits, and costs. Second, the new plan requires changes in risk assessment to provide the necessary foundation for the new economic evaluation of risks, benefits, and costs. The advantages and disadvantages of the new regulatory plan are discussed.

摘要

1996年管理与预算办公室(OMB)文件实施的1993年第12866号行政命令提出了一种评估风险、收益和成本的新范式。新的监管计划将在两个方面取代现行方法。新监管计划建立了一套风险、收益和成本经济评估的先进指南,以取代当前基于保守的一般默认假设进行风险评估的方法,这种假设提供一个被视为“收益”的上限风险值。其次,新计划要求风险评估做出改变,以便为新的风险、收益和成本经济评估提供必要的基础。本文讨论了新监管计划的优缺点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验